Molbio Diagnostics a Molecular Diagnostic chain has raised $85 million, around INR 693 crore (1 USD = INR 81.59), in a funding round led by Singapore-based Temasek. The funding was done on the valuation of a Unicorn. Molbio enables precise, rapid, cost-effective molecular diagnosis at the point of care.
The Funds raised will further accelerate Molbio’s ability to develop near-care technologies tackling clinic need gaps and expand its proprietary platform globally. Molbio will become 108th Unicorn so far in India.
The Truelab Real-Time quantitative micro PCR system from Molbio Diagnostics brings PCR technology right to the point-of-care, at all laboratory and non-laboratory settings, primary centres, in the field, near-patient, essentially at all levels of healthcare thereby decentralizing and democratising access to molecular diagnostics. The platform is infrastructure independent and provides a complete end-to-end solution for disease diagnosis.